Fermented Ingredients Drive Health, Flavour, and Reformulation in UK Supplements
Manufacturers leverage fermentation for gut health and protein applications, enabling sugar reduction and cleaner labels. This strategy balances consumer demand for functionality with taste appeal, critical for market adoption.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 19 October 2026
Fermentation is emerging as a critical process for supplement manufacturers targeting gut health, high-protein formulations, and simplified ingredient lists. Industry leaders, including Danone, Novonesis, and Daesang, confirm that while health benefits attract initial interest, consumer retention hinges on taste and texture. This balance is pivotal for commercial success and sustained market growth, as taste and enjoyment remain non-negotiable for everyday product integration.
Danone highlights gut health and protein content as primary innovation drivers within its fermented portfolio. Their Activia Kefir, for instance, blends Activia live cultures with kefir yeasts across 16 strains. The company’s access to over 1,900 strains enables precise manipulation of acidity, flavour, and texture, allowing for sophisticated product profiles without extensive ingredient decks. Novonesis corroborates this, noting strong interest in cultures for high-protein, lower-sugar dairy applications and plant-based alternatives that require fermentation to build texture and simplify recipes. Enzymes, in conjunction with cultures, offer additional flexibility in resolving formulation challenges, such as managing viscosity in high-protein dairy products.
Fermentation also provides a direct route to 'cleaner label' products by developing desired qualities inherently during production, thus reducing the need for external additives. Danone’s experience with Actimel, where fermentation contributed to a 28% sugar reduction since 1998, exemplifies its potential for impactful reformulation. While precision fermentation for protein production shows promise, scaling laboratory breakthroughs to industrial levels remains a significant hurdle. Facilities like the Biotech Open Platform in France are addressing this by supporting bioprocess development to bridge the gap to commercialisation.
Beyond traditional supplements, fermented ingredients from culinary applications, such as kimchi and gochujang, offer new flavour and functional avenues. Daesang leverages their inherent complexity – combining umami, sweetness, and spice – to enhance marinades, dressings, and convenience foods. Innova Market Insights data indicates a 15% increase in F&B launches featuring kimchi flavour between October 2021 and September 2026, signalling a broader market receptivity to such profiles.
Consistency in fermented products necessitates rigorous process control. Daesang manages ambient kimchi’s flavour and quality through heat treatment post-fermentation, extending shelf life. For probiotic supplements, maintaining cell count viability throughout the product’s shelf life is paramount, as advised by Novonesis. The count must match levels validated by clinical studies to substantiate health claims, making formulation stability (e.g., Novonesis’ ProSilience HU58) a key differentiator. Critical regulatory compliance dictates clear communication differentiating fermentation as a process from specific health benefits, which vary significantly by product and processing method.
What this means for United Kingdom
UK supplement manufacturers must prioritise investment in culture development and fermentation expertise to meet growing consumer demand for gut health and plant-based protein supplements. Regulatory scrutiny from the MHRA and FSA on probiotic health claims requires robust stability data, impacting formulation and packaging choices to ensure declared cell counts are maintained until expiry. Brand owners can leverage familiar fermented flavours, like those found in global cuisines, to broaden appeal beyond traditional health-focused products, targeting the 15% increase in market interest for such profiles. Reformulation opportunities exist for sugar reduction and cleaner label claims, offering a competitive edge for products positioned at Boots or Holland & Barrett.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.